Literature DB >> 20672742

Regulatory T cells (TREG) and their roles in immune system with respect to immunopathological disorders.

Katerina Kondĕlková1, Doris Vokurková, Jan Krejsek, Lenka Borská, Zdenĕk Fiala, Andrýs Ctirad.   

Abstract

Regulatory T cells (Tregs) are a specialized subpopulation of T cells that act to suppress immune response, thereby maintaining homeostasis and self-tolerance. It has been shown that Tregs are able to inhibit T cell proliferation and cytokine production and play a critical role in preventing autoimmunity. Different subsets with various functions of Treg cells exist. Tregs can be usually identified by flow cytometry. The most specific marker for these cells is FoxP3, which is localized intracellulary. Selected surface markers such as CD25high (high molecular density) and CD127low (low molecular density) could serve as surrogate markers to detect Tregs in a routine clinical practice. Dysregulation in Treg cell frequency or functions may lead to the development of autoimmune disease. Therapeutical Treg modulation is considered to be a promising therapeutical approach to treat some selected disorders, such as allergies, and to prevent allograft rejection.

Entities:  

Mesh:

Year:  2010        PMID: 20672742     DOI: 10.14712/18059694.2016.63

Source DB:  PubMed          Journal:  Acta Medica (Hradec Kralove)        ISSN: 1211-4286


  52 in total

1.  Urinary trypsin inhibitor attenuated inflammatory response of patients undergoing cardiopulmonary bypass by inducing activated Treg cells.

Authors:  Xing Hao; Junyan Han; Zhichen Xing; Yu Hao; Chunjing Jiang; Jianping Zhang; Jing Yang; Xiaotong Hou
Journal:  Inflammation       Date:  2013-12       Impact factor: 4.092

Review 2.  Mathematical modeling of tumor-immune cell interactions.

Authors:  Grace E Mahlbacher; Kara C Reihmer; Hermann B Frieboes
Journal:  J Theor Biol       Date:  2019-03-02       Impact factor: 2.691

Review 3.  Nanomedicines for Endometriosis: Lessons Learned from Cancer Research.

Authors:  Abraham S Moses; Ananiya A Demessie; Olena Taratula; Tetiana Korzun; Ov D Slayden; Oleh Taratula
Journal:  Small       Date:  2021-01-25       Impact factor: 13.281

Review 4.  Alterations in regulatory T-cells: rediscovered pathways in immunotoxicology.

Authors:  Emanuela Corsini; Mohamed Oukka; Raymond Pieters; Nancy I Kerkvliet; Rafael Ponce; Dori R Germolec
Journal:  J Immunotoxicol       Date:  2011-08-17       Impact factor: 3.000

Review 5.  Harnessing the immune system against cancer: current immunotherapy approaches and therapeutic targets.

Authors:  Aswathy R Devan; Bhagyalakshmi Nair; Ayana R Kumar; Balachandran S Vinod; Lekshmi R Nath
Journal:  Mol Biol Rep       Date:  2021-10-20       Impact factor: 2.316

6.  Shear Stress Enhances the Paracrine-Mediated Immunoregulatory Function of Human Periodontal Ligament Stem Cells via the ERK Signalling Pathway.

Authors:  Ravipha Suwittayarak; Nuttha Klincumhom; Utapin Ngaokrajang; Worachat Namangkalakul; João N Ferreira; Prasit Pavasant; Thanaphum Osathanon
Journal:  Int J Mol Sci       Date:  2022-06-27       Impact factor: 6.208

7.  Impact and Clinical Implications of Prematurity on Adaptive Immune Development.

Authors:  Emma Idzikowski; Thomas J Connors
Journal:  Curr Pediatr Rep       Date:  2020-10-26

8.  Influence of short-term glucocorticoid therapy on regulatory T cells in vivo.

Authors:  Silviu Sbiera; Thomas Dexneit; Sybille D Reichardt; Kai D Michel; Jens van den Brandt; Sebastian Schmull; Luitgard Kraus; Melanie Beyer; Robert Mlynski; Sebastian Wortmann; Bruno Allolio; Holger M Reichardt; Martin Fassnacht
Journal:  PLoS One       Date:  2011-09-02       Impact factor: 3.240

Review 9.  Vagus Nerve Stimulation and the Cardiovascular System.

Authors:  Michael J Capilupi; Samantha M Kerath; Lance B Becker
Journal:  Cold Spring Harb Perspect Med       Date:  2020-02-03       Impact factor: 6.915

Review 10.  Regulatory T-Cells as an Emerging Barrier to Immune Checkpoint Inhibition in Lung Cancer.

Authors:  Daniel R Principe; Lauren Chiec; Nisha A Mohindra; Hidayatullah G Munshi
Journal:  Front Oncol       Date:  2021-06-01       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.